Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MN”

60 trials

Showing 20 of 60 results

Not applicableUnknownNCT04800705
What this trial is testing

Levels of Selected Macroelements in Premature Ovarian Insufficiency

Who this might be right for
Premature Ovarian Failure
Cengiz Gokcek Women's and Children's Hospital 140
Not applicableUnknownNCT01253057
What this trial is testing

A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs Exposure

Who this might be right for
Sister-chromatic-exchange(SCE)Micronuclei(MN)
Taipei Medical University WanFang Hospital 200
Not applicableUnknownNCT05383547
What this trial is testing

Bortezomib for Treating Glomerular Diseases

Who this might be right for
BortezomibGlomerulonephritisMN+3 more
Ruijin Hospital 20
Not applicableStudy completedNCT05148455
What this trial is testing

Pregnancy-related Changes in Melanocytic Nevi

Who this might be right for
Melanocytic Nevi (MN)
University Hospital, Basel, Switzerland 50
Early research (Phase 1)Study completedNCT00000868
What this trial is testing

Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableUnknownNCT05667922
What this trial is testing

Prognostic Model of TAC in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Early research (Phase 1)Study completedNCT00000775
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableUnknownNCT05667896
What this trial is testing

Prognostic Model of GC/TAC in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Post-approval studies (Phase 4)Study completedNCT00518219
What this trial is testing

To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)

Who this might be right for
Membranous Nephropathy
Nanjing University School of Medicine 68
Not applicableLooking for participantsNCT07037927
What this trial is testing

Minnesota RETAIN Phase 3

Who this might be right for
Injuries Related WorkIllness Related WorkDisability
Mayo Clinic 1,000
Not applicableStudy completedNCT00000866
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Ended earlyNCT00460460
What this trial is testing

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Who this might be right for
Lymphoma
AstraZeneca 75
Not applicableUnknownNCT05667883
What this trial is testing

Prognostic Model of GC/CTX in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01093157
What this trial is testing

A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

Who this might be right for
Glomerulonephritis
University Health Network, Toronto 10
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00000846
What this trial is testing

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00001052
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT00000822
What this trial is testing

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 46
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation